Correlation Between ScanSource and Inhibrx

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both ScanSource and Inhibrx at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ScanSource and Inhibrx into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between ScanSource and Inhibrx, you can compare the effects of market volatilities on ScanSource and Inhibrx and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ScanSource with a short position of Inhibrx. Check out your portfolio center. Please also check ongoing floating volatility patterns of ScanSource and Inhibrx.

Diversification Opportunities for ScanSource and Inhibrx

-0.28
  Correlation Coefficient

Very good diversification

The 3 months correlation between ScanSource and Inhibrx is -0.28. Overlapping area represents the amount of risk that can be diversified away by holding ScanSource and Inhibrx in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Inhibrx and ScanSource is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ScanSource are associated (or correlated) with Inhibrx. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Inhibrx has no effect on the direction of ScanSource i.e., ScanSource and Inhibrx go up and down completely randomly.

Pair Corralation between ScanSource and Inhibrx

Given the investment horizon of 90 days ScanSource is expected to generate 0.35 times more return on investment than Inhibrx. However, ScanSource is 2.83 times less risky than Inhibrx. It trades about 0.18 of its potential returns per unit of risk. Inhibrx is currently generating about -0.17 per unit of risk. If you would invest  4,905  in ScanSource on October 26, 2024 and sell it today you would earn a total of  216.00  from holding ScanSource or generate 4.4% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

ScanSource  vs.  Inhibrx

 Performance 
       Timeline  
ScanSource 

Risk-Adjusted Performance

7 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in ScanSource are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of rather weak basic indicators, ScanSource exhibited solid returns over the last few months and may actually be approaching a breakup point.
Inhibrx 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Inhibrx has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's fundamental drivers remain fairly strong which may send shares a bit higher in February 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

ScanSource and Inhibrx Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with ScanSource and Inhibrx

The main advantage of trading using opposite ScanSource and Inhibrx positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ScanSource position performs unexpectedly, Inhibrx can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Inhibrx will offset losses from the drop in Inhibrx's long position.
The idea behind ScanSource and Inhibrx pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.

Other Complementary Tools

Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
CEOs Directory
Screen CEOs from public companies around the world
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing